Mineralys Therapeutics, Inc.

Q1 2025 13F Holders

Symbol
MLYS
CUSIP
603170101
Type
Equity
Class
COM
Num filings
166
Total reported value, excl. options
$972 M
Manager Report Date Value ($000) Shares Option Type